Intrinsic Value of S&P & Nasdaq Contact Us

NuVasive, Inc. NUVA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$58.00
+45.9%

Stock Statistics — NUVA

NuVasive, Inc. (NUVA) has a market capitalization of $2.08B and trades at $39.75. The 52-week range is 35.17-49.53.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 51, Earnings Per Share (EPS) of $0.78, annual revenue of $1.2B.

The stock has a beta of 1.07, operates in the Healthcare sector.

Trading Data
Current Price$39.75
52-Week Range35.17-49.53
Volume30.59M
Avg Volume (30D)1.41M
Market Cap$2.08B
Beta (1Y)1.07
Company
IPO Date2004-05-13
Employees3,000
CEOJ. Christopher Barry
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS6707041058
CUSIP670704105
Income (Latest Year)
Revenue$1.2B
Gross Profit$865.44M
EBITDA$211.8M
Operating Income$64.77M
Net Income$40.41M
EPS$0.78
EPS Diluted$0.76
Shares Outstanding$57.36M
Balance Sheet (Latest Year)
Total Assets$2.22B
Current Assets$865.21M
Cash & ST Investments$248.66M
Total Liabilities$1.36B
Total Debt$1.01B
Net Debt$757.42M
Total Equity$868.89M
Debt / Equity1.16
Valuation Ratios
P/E Ratio51
P/S Ratio1.73
P/B Ratio2.4
EV/EBITDA (approx)9.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message